+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anatomic Pathology Market - Global Forecast 2026-2032- Product Image
Anatomic Pathology Market - Global Forecast 2026-2032- Product Image
Sale

Anatomic Pathology Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 4896599
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Anatomic Pathology Market is projected to reach USD 44.80 Billion in 2026. It is expected to continue growing at a CAGR of 8.90%, reaching USD 75.04 Billion by 2032.

Anatomic pathology sits at the center of cancer diagnosis, tissue-based disease characterization, transplant evaluation, inflammatory disease workups, and precision medicine. The discipline spans histopathology, cytopathology, immunohistochemistry, in situ hybridization, molecular pathology, autopsy pathology, and surgical pathology workflows that convert tissue specimens into clinically actionable diagnoses.

Demand is structurally supported by rising cancer incidence, aging populations, and the continued expansion of biomarker-driven oncology. The International Agency for Research on Cancer reported about 20 million new cancer cases and 9.7 million cancer deaths worldwide in 2022, reinforcing the indispensable role of pathology laboratories in early detection, tumor classification, staging, grading, and therapy selection.

The market is also being reshaped by digital pathology, laboratory automation, companion diagnostics, and artificial intelligence-enabled image analysis. Health systems and diagnostic networks are prioritizing turnaround time, quality assurance, pathologist productivity, integrated reporting, and tissue stewardship as specimen volumes increase and subspecialty expertise remains unevenly distributed across geographies.

Transformative Shifts in the Anatomic Pathology Landscape

The most important shift in anatomic pathology is the movement from microscope-centered workflows to data-rich diagnostic ecosystems. Whole slide imaging, laboratory information systems, image management platforms, and interoperable reporting tools are enabling remote review, tumor boards, education, archiving, and quality control across distributed networks.

Precision oncology is another major force. Immunohistochemistry, fluorescence in situ hybridization, next-generation sequencing triage, and companion diagnostic testing are increasingly embedded in routine tissue workflows. This is raising expectations for standardized pre-analytics, validated assays, tissue stewardship, and faster reflex testing pathways that preserve limited biopsy material.

Regulation is becoming more consequential. In the United States, CLIA oversight, College of American Pathologists accreditation, and the FDA's 2024 final rule on laboratory developed tests are influencing validation, documentation, and risk management. In Europe, the In Vitro Diagnostic Regulation is reshaping conformity assessment and evidence expectations for diagnostic products used in pathology laboratories.

Cumulative Impact of Artificial Intelligence in Anatomic Pathology

Artificial intelligence is adding cumulative value across anatomic pathology rather than replacing pathologists. AI-assisted tools are being applied to case prioritization, mitotic counting, tumor detection, biomarker quantification, quality checks, workload balancing, and research-grade feature extraction from whole slide images.

Regulatory milestones have validated the clinical direction of the field. The U.S. Food and Drug Administration authorized the first whole slide imaging system for primary diagnostic use in 2017, and subsequent clearances for AI-assisted pathology applications have demonstrated growing acceptance of software as a medical device when supported by analytical and clinical validation.

The cumulative impact is operational and clinical. AI can reduce repetitive measurement burden, flag regions of interest, improve reproducibility in quantitative assays, and support subspecialty consultation in underserved areas. However, adoption depends on scanner standardization, data governance, cybersecurity, algorithm monitoring, bias assessment, pathologist oversight, and clear reimbursement or productivity justification.

Key Regional Insights Across Global Anatomic Pathology

North America remains a leading region for anatomic pathology because of high cancer screening uptake, mature hospital networks, reference laboratory scale, CAP-accredited quality systems, and early adoption of digital pathology. The United States drives much of the regional momentum through oncology diagnostics, academic medical centers, laboratory developed testing expertise, and reference laboratory networks, while Canada emphasizes publicly funded cancer care pathways, provincial pathology modernization, and quality-based diagnostic access.

Europe combines strong academic pathology expertise with regulatory transformation under the EU In Vitro Diagnostic Regulation. Germany, France, Italy, Spain, and the United Kingdom are advancing cancer diagnostics, biobanking, digital health infrastructure, and genomics-enabled care, although procurement cycles, workforce pressures, and data protection requirements can slow implementation. Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN health systems address growing cancer burdens, urban hospital capacity, organized screening initiatives, and the need for standardized pathology quality.

Latin America, the Middle East, and Africa show rising need for tissue diagnostics tied to oncology expansion, infectious disease pathology, and increasing use of immunohistochemistry and molecular testing, but access remains uneven. Brazil and Mexico anchor Latin American demand through large public and private healthcare networks, Middle Eastern countries are investing in tertiary care, oncology centers, and laboratory accreditation, and African markets are focused on workforce development, sample logistics, external quality assessment, and regional reference testing models to improve access to reliable anatomic pathology services.

Key Group Insights for Anatomic Pathology Markets

ASEAN is gaining importance as Indonesia, Thailand, Vietnam, Malaysia, the Philippines, and Singapore expand hospital capacity and cancer care networks. Singapore acts as a regional hub for advanced diagnostics, digital health, and clinical research, while larger ASEAN markets require scalable pathology solutions that address affordability, workforce shortages, quality standardization, and specimen transport from secondary cities to centralized laboratories.

The GCC is investing in advanced tertiary care, oncology centers, laboratory accreditation, and digital health platforms, making it a significant corridor for premium pathology instrumentation, outsourced diagnostic partnerships, and quality-led modernization. The European Union is shaped by IVDR compliance, cross-border research programs, cancer mission initiatives, and strong public health systems, creating demand for validated diagnostics, traceable workflows, interoperable data systems, and evidence-based digital pathology adoption.

BRICS countries represent high-volume pathology environments because Brazil, Russia, India, China, and South Africa combine large patient populations with expanding oncology infrastructure and variable access to subspecialty expertise. G7 markets remain innovation leaders in digital pathology, molecular integration, clinical validation, and AI governance. NATO countries overlap substantially with advanced North American and European diagnostic systems, where resilience, cybersecurity, continuity planning, and secure medical data infrastructure are increasingly relevant to laboratory modernization.

Key Country Insights in Anatomic Pathology

The United States is the most influential country market, supported by large cancer care networks, commercial and academic reference laboratories, CLIA-certified testing, CAP accreditation, and strong adoption of companion diagnostics. Canada prioritizes centralized cancer programs, provincial quality standards, and equitable diagnostic pathways, while Mexico and Brazil are expanding private and public diagnostic capacity to address rising oncology needs across large and geographically diverse populations.

In Europe, the United Kingdom has invested in genomics, cancer diagnostic capacity, and digital pathology initiatives through the National Health Service, while Germany benefits from advanced laboratory infrastructure, strong medical technology adoption, and established pathology expertise. France, Italy, and Spain combine universal health systems with active cancer screening, hospital-based pathology networks, and increasing interest in molecular pathology, while Russia maintains demand through large tertiary hospitals and oncology centers despite procurement and geopolitical constraints.

China and India are high-priority anatomic pathology markets due to large disease burdens, hospital expansion, growing cancer screening activity, and increasing use of immunohistochemistry, histochemistry, and molecular pathology. Japan and South Korea are advanced markets with strong cancer diagnostics, automation, digital health capacity, and precision medicine infrastructure, while Australia benefits from organized cancer screening, high-quality pathology standards, accreditation culture, and regional leadership in digital health implementation.

Actionable Recommendations for Anatomic Pathology Leaders

Industry leaders should prioritize end-to-end workflow modernization rather than isolated technology purchases. Successful programs link specimen tracking, grossing, tissue processing, staining, slide scanning, reporting, archiving, and quality management into measurable productivity, turnaround time, and diagnostic quality outcomes.

Vendors and laboratories should invest in regulatory-grade validation, cybersecurity, interoperability, and pathologist-centered design. AI deployment should begin with high-value use cases such as triage, quality control, biomarker quantification, and workload optimization, with post-implementation monitoring, documented performance metrics, and transparent governance.

Commercial strategies should be region-specific. Mature markets need differentiated digital pathology platforms, automation, integrated molecular workflows, and evidence-based AI, while emerging markets need affordable instruments, training, remote consultation networks, external quality assessment, and accredited reference laboratory partnerships that improve access without compromising diagnostic quality.

Research Methodology for Anatomic Pathology Analysis

This executive summary is based on secondary research from publicly available and authoritative sources, including the World Health Organization, International Agency for Research on Cancer, U.S. Food and Drug Administration, Centers for Medicare & Medicaid Services, College of American Pathologists, European Commission, national cancer agencies, peer-reviewed literature, and major health system publications.

The analysis evaluates market drivers, regulatory developments, technology adoption, regional health infrastructure, workforce considerations, and country-level diagnostic capacity. Insights were cross-checked against recognized clinical and policy references to avoid unsupported assumptions and to ensure that the conclusions reflect verifiable trends in anatomic pathology, digital pathology, AI-enabled diagnostics, laboratory automation, and precision oncology.

Conclusion: The Future of Anatomic Pathology

Anatomic pathology is evolving from a predominantly manual diagnostic specialty into an integrated, digitally enabled, and biomarker-driven foundation of precision medicine. Rising cancer incidence, expanding tissue-based testing, and growing demand for faster and more reproducible diagnoses are strengthening its role across healthcare systems.

The next phase of leadership will favor organizations that combine scientific rigor, workflow efficiency, regulatory readiness, interoperability, and responsible AI adoption. Laboratories, technology vendors, and healthcare providers that align innovation with quality, access, data security, and clinical trust will be best positioned to create long-term value in global anatomic pathology.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.1.1. Expanding cancer-related diagnostic need
4.3.1.2. Precision oncology and therapy-linked testing
4.3.1.3. Digitization of pathology workflows
4.3.1.4. Automation, consistency, and laboratory safety
4.3.1.5. Recurring workflow economics
4.3.2. Key Restraints
4.3.2.1. Capital intensity and expenditure cycles
4.3.2.2. Fragmented regulatory pathways
4.3.2.3. Validation and interoperability barriers
4.3.2.4. Uneven pathology capacity
4.3.2.5. Unequal funding for cancer services
4.3.2.6. Cybersecurity and lifecycle obligations
4.3.2.7. Chemical, occupational, and facility burdens
4.3.3. Key Opportunities
4.3.3.1. Interoperable digital pathology platforms
4.3.3.2. Recurring access and managed services
4.3.3.3. Pathology capacity development
4.3.3.4. Multichannel commercial expansion
4.3.3.5. Safer and more controlled preparation workflows
4.3.4. Key Challenges
4.3.4.1. Regulatory portfolio sequencing
4.3.4.2. Shared cybersecurity governance
4.3.4.3. Generalizing digital and analytical performance
4.3.4.4. Regional service execution
4.3.4.5. Aligning recurring-contract economics
4.3.4.6. Integrating technology into physical laboratories
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Anatomic Pathology Market, by Offering
7.1. Introduction
7.2. Reagents & Consumables
7.2.1. Antibodies & Reagents
7.2.2. Slides & Coverslips
7.2.3. Kits & Assay Systems
7.2.4. Cassettes & Embedding Media
7.3. Instruments & Equipment
7.3.1. Slide-Staining Systems
7.3.2. Microscopes
7.3.3. Tissue Processing Systems
7.3.4. Microtomes
7.3.5. Embedding Systems
7.3.6. Pathology Scanners
7.3.7. Grossing Stations
7.3.8. Tissue Homogenizers
7.4. Associated Services
7.5. Software
7.5.1. Laboratory Information Systems
7.5.2. Image Analysis & AI Software
7.5.3. Pathology Viewers & Image Management
7.5.4. Workflow Management Software
8. Anatomic Pathology Market, by Workflow Stage
8.1. Introduction
8.2. Staining & Labeling
8.3. Processing & Embedding
8.4. Sectioning & Slide Preparation
8.5. Workflow Orchestration & Reporting
8.6. Analysis & Interpretation Support
8.7. Imaging & Digitization
8.8. Grossing & Fixation
8.9. Accessioning & Identification
8.10. Archiving & Retrieval
9. Anatomic Pathology Market, by Specimen Discipline
9.1. Introduction
9.2. Histopathology
9.3. Cytopathology
10. Anatomic Pathology Market, by Diagnostic Technique
10.1. Introduction
10.2. Immunohistochemistry & Immunocytochemistry
10.3. Histochemical Staining
10.4. Conventional Microscopy
10.5. Digital Slide Imaging
10.6. In Situ Hybridization
10.7. Computational Image Analysis
11. Anatomic Pathology Market, by Clinical Purpose
11.1. Introduction
11.2. Diagnosis, Classification & Staging
11.3. Prognosis & Risk Stratification
11.4. Therapy Selection
11.5. Screening & Early Detection
11.6. Drug Development & Translational Research
11.7. Treatment Response & Disease Monitoring
12. Anatomic Pathology Market, by End User
12.1. Introduction
12.2. Hospitals & Health Systems
12.3. Independent & Reference Laboratories
12.4. Pharmaceutical & Biotechnology Companies
12.5. Academic & Research Institutions
12.6. Contract Research & Central Laboratories
12.7. Public Health Laboratories
13. Anatomic Pathology Market, by Automation Level
13.1. Introduction
13.2. Semi-Automated
13.3. Fully Automated
13.4. Manual
14. Anatomic Pathology Market, by Commercial Access Model
14.1. Introduction
14.2. Capital Purchase
14.3. Consumable-Linked Placement
14.4. Fixed-Term Rental & Subscription
15. Anatomic Pathology Market, by Route to Market
15.1. Introduction
15.2. Direct Account Sales
15.3. Distributors & Resellers
15.4. Digital Commerce
16. Anatomic Pathology Market, by Region
16.1. Introduction
16.2. Europe
16.3. North America
16.4. Asia-Pacific
16.5. Latin America
16.6. Middle East
16.7. Africa
17. Anatomic Pathology Market, by Group
17.1. Introduction
17.2. NATO
17.3. G7
17.4. European Union
17.5. BRICS
17.6. ASEAN
17.7. GCC
18. Anatomic Pathology Market, by Country
18.1. Introduction
18.2. United States
18.3. Germany
18.4. China
18.5. France
18.6. United Kingdom
18.7. Japan
18.8. Italy
18.9. Canada
18.10. Brazil
18.11. India
18.12. Spain
18.13. Russia
18.14. Australia
18.15. Mexico
18.16. South Korea
19. Competitive Landscape
19.1. Market Share Analysis, 2025
19.2. Market Concentration Analysis, 2025
19.2.1. Concentration Ratio (CR)
19.2.2. Herfindahl Hirschman Index (HHI)
19.3. Recent Developments & Impact Analysis, 2025
19.4. Product Portfolio Analysis, 2025
19.5. Benchmarking Analysis, 2025
20. Company Profiles
20.1. Roche Holding Ltd
20.2. Danaher Corporation
20.3. Agilent Technologies, Inc.
20.4. PHC Holdings Corporation
20.5. Hamamatsu Photonics K.K.
20.6. Hologic, Inc.
20.7. Milestone SpA
20.8. 3DHISTECH Kft.
20.9. Bio-Optica Milano S.p.A.
21. Key Experts
List of Figures
FIGURE 1. Global Anatomic Pathology Market, Years Considered for the Study
FIGURE 2. Global Anatomic Pathology Market, Research Design
FIGURE 3. Global Anatomic Pathology Market, Research Framework
FIGURE 4. Global Anatomic Pathology Market, Data Triangulation
FIGURE 5. Global Anatomic Pathology Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Anatomic Pathology Market Size, by Offering, 2025 vs 2032 (%)
FIGURE 7. Global Anatomic Pathology Market Size, by Offering, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Anatomic Pathology Market Size, by Workflow Stage, 2025 vs 2032 (%)
FIGURE 9. Global Anatomic Pathology Market Size, by Workflow Stage, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Anatomic Pathology Market Size, by Specimen Discipline, 2025 vs 2032 (%)
FIGURE 11. Global Anatomic Pathology Market Size, by Specimen Discipline, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Anatomic Pathology Market Size, by Diagnostic Technique, 2025 vs 2032 (%)
FIGURE 13. Global Anatomic Pathology Market Size, by Diagnostic Technique, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Anatomic Pathology Market Size, by Clinical Purpose, 2025 vs 2032 (%)
FIGURE 15. Global Anatomic Pathology Market Size, by Clinical Purpose, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Anatomic Pathology Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Anatomic Pathology Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Anatomic Pathology Market Size, by Automation Level, 2025 vs 2032 (%)
FIGURE 19. Global Anatomic Pathology Market Size, by Automation Level, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Anatomic Pathology Market Size, by Commercial Access Model, 2025 vs 2032 (%)
FIGURE 21. Global Anatomic Pathology Market Size, by Commercial Access Model, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Anatomic Pathology Market Size, by Route to Market, 2025 vs 2032 (%)
FIGURE 23. Global Anatomic Pathology Market Size, by Route to Market, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Anatomic Pathology Market Size, by Region, 2025 vs 2032 (%)
FIGURE 25. Global Anatomic Pathology Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 26. Global Anatomic Pathology Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Anatomic Pathology Market Size, by Country, 2025 vs 2032 (%)
FIGURE 28. Global Anatomic Pathology Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 29. Global Anatomic Pathology Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Anatomic Pathology Market Segmentation & Coverage
TABLE 2. Global Anatomic Pathology Market Size, 2017-2032 (USD Million)
TABLE 3. Global Anatomic Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 4. Global Reagents & Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Reagents & Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Reagents & Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Antibodies & Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Antibodies & Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Antibodies & Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Slides & Coverslips Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Slides & Coverslips Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Slides & Coverslips Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Kits & Assay Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Kits & Assay Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Kits & Assay Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Cassettes & Embedding Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Cassettes & Embedding Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Cassettes & Embedding Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Instruments & Equipment Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Instruments & Equipment Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Instruments & Equipment Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Slide-Staining Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Slide-Staining Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Slide-Staining Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Microscopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Microscopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Microscopes Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Tissue Processing Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Tissue Processing Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Tissue Processing Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Microtomes Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Microtomes Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Microtomes Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Embedding Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Embedding Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Embedding Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Pathology Scanners Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Pathology Scanners Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Pathology Scanners Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Grossing Stations Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Grossing Stations Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Grossing Stations Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Tissue Homogenizers Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Tissue Homogenizers Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Tissue Homogenizers Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Associated Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Associated Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Associated Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Laboratory Information Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Laboratory Information Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Laboratory Information Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Image Analysis & AI Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Image Analysis & AI Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Image Analysis & AI Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Pathology Viewers & Image Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Pathology Viewers & Image Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Pathology Viewers & Image Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Workflow Management Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Workflow Management Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Workflow Management Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Anatomic Pathology Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 65. Global Staining & Labeling Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Staining & Labeling Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Staining & Labeling Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Processing & Embedding Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Processing & Embedding Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Processing & Embedding Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Sectioning & Slide Preparation Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Sectioning & Slide Preparation Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Sectioning & Slide Preparation Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Workflow Orchestration & Reporting Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Workflow Orchestration & Reporting Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Workflow Orchestration & Reporting Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Analysis & Interpretation Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Analysis & Interpretation Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Analysis & Interpretation Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Imaging & Digitization Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Imaging & Digitization Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Imaging & Digitization Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Grossing & Fixation Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Grossing & Fixation Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Grossing & Fixation Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Accessioning & Identification Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Accessioning & Identification Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Accessioning & Identification Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Archiving & Retrieval Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Archiving & Retrieval Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Archiving & Retrieval Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Anatomic Pathology Market Size, by Specimen Discipline, 2017-2032 (USD Million)
TABLE 93. Global Histopathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Histopathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Histopathology Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Cytopathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Cytopathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Cytopathology Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Anatomic Pathology Market Size, by Diagnostic Technique, 2017-2032 (USD Million)
TABLE 100. Global Immunohistochemistry & Immunocytochemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Immunohistochemistry & Immunocytochemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Immunohistochemistry & Immunocytochemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Histochemical Staining Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Histochemical Staining Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Histochemical Staining Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Conventional Microscopy Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Conventional Microscopy Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Conventional Microscopy Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Digital Slide Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Digital Slide Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Digital Slide Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global In Situ Hybridization Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global In Situ Hybridization Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global In Situ Hybridization Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Computational Image Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Computational Image Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Computational Image Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Anatomic Pathology Market Size, by Clinical Purpose, 2017-2032 (USD Million)
TABLE 119. Global Diagnosis, Classification & Staging Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Diagnosis, Classification & Staging Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Diagnosis, Classification & Staging Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Prognosis & Risk Stratification Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Prognosis & Risk Stratification Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Prognosis & Risk Stratification Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Therapy Selection Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Therapy Selection Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Therapy Selection Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Screening & Early Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Screening & Early Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Screening & Early Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Drug Development & Translational Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Drug Development & Translational Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Drug Development & Translational Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Treatment Response & Disease Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Treatment Response & Disease Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Treatment Response & Disease Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Anatomic Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. Global Hospitals & Health Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Hospitals & Health Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Hospitals & Health Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Independent & Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Independent & Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Independent & Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. Global Academic & Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Global Academic & Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. Global Academic & Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 150. Global Contract Research & Central Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Global Contract Research & Central Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. Global Contract Research & Central Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. Global Public Health Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Global Public Health Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. Global Public Health Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 156. Global Anatomic Pathology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 157. Global Semi-Automated Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Global Semi-Automated Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. Global Semi-Automated Market Size, by Country, 2017-2032 (USD Million)
TABLE 160. Global Fully Automated Market Size, by Region, 2017-2032 (USD Million)
TABLE 161. Global Fully Automated Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. Global Fully Automated Market Size, by Country, 2017-2032 (USD Million)
TABLE 163. Global Manual Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Global Manual Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. Global Manual Market Size, by Country, 2017-2032 (USD Million)
TABLE 166. Global Anatomic Pathology Market Size, by Commercial Access Model, 2017-2032 (USD Million)
TABLE 167. Global Capital Purchase Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Global Capital Purchase Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. Global Capital Purchase Market Size, by Country, 2017-2032 (USD Million)
TABLE 170. Global Consumable-Linked Placement Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Global Consumable-Linked Placement Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. Global Consumable-Linked Placement Market Size, by Country, 2017-2032 (USD Million)
TABLE 173. Global Fixed-Term Rental & Subscription Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Global Fixed-Term Rental & Subscription Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. Global Fixed-Term Rental & Subscription Market Size, by Country, 2017-2032 (USD Million)
TABLE 176. Global Anatomic Pathology Market Size, by Route to Market, 2017-2032 (USD Million)
TABLE 177. Global Direct Account Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Global Direct Account Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. Global Direct Account Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 180. Global Distributors & Resellers Market Size, by Region, 2017-2032 (USD Million)
TABLE 181. Global Distributors & Resellers Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. Global Distributors & Resellers Market Size, by Country, 2017-2032 (USD Million)
TABLE 183. Global Digital Commerce Market Size, by Region, 2017-2032 (USD Million)
TABLE 184. Global Digital Commerce Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. Global Digital Commerce Market Size, by Country, 2017-2032 (USD Million)
TABLE 186. Global Anatomic Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Europe Anatomic Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 188. Europe Anatomic Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 189. Europe Anatomic Pathology Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 190. Europe Anatomic Pathology Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 191. Europe Anatomic Pathology Market Size, by Software, 2017-2032 (USD Million)
TABLE 192. Europe Anatomic Pathology Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 193. Europe Anatomic Pathology Market Size, by Specimen Discipline, 2017-2032 (USD Million)
TABLE 194. Europe Anatomic Pathology Market Size, by Diagnostic Technique, 2017-2032 (USD Million)
TABLE 195. Europe Anatomic Pathology Market Size, by Clinical Purpose, 2017-2032 (USD Million)
TABLE 196. Europe Anatomic Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. Europe Anatomic Pathology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 198. Europe Anatomic Pathology Market Size, by Commercial Access Model, 2017-2032 (USD Million)
TABLE 199. Europe Anatomic Pathology Market Size, by Route to Market, 2017-2032 (USD Million)
TABLE 200. North America Anatomic Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 201. North America Anatomic Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 202. North America Anatomic Pathology Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 203. North America Anatomic Pathology Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 204. North America Anatomic Pathology Market Size, by Software, 2017-2032 (USD Million)
TABLE 205. North America Anatomic Pathology Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 206. North America Anatomic Pathology Market Size, by Specimen Discipline, 2017-2032 (USD Million)
TABLE 207. North America Anatomic Pathology Market Size, by Diagnostic Technique, 2017-2032 (USD Million)
TABLE 208. North America Anatomic Pathology Market Size, by Clinical Purpose, 2017-2032 (USD Million)
TABLE 209. North America Anatomic Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. North America Anatomic Pathology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 211. North America Anatomic Pathology Market Size, by Commercial Access Model, 2017-2032 (USD Million)
TABLE 212. North America Anatomic Pathology Market Size, by Route to Market, 2017-2032 (USD Million)
TABLE 213. Asia-Pacific Anatomic Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 214. Asia-Pacific Anatomic Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 215. Asia-Pacific Anatomic Pathology Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 216. Asia-Pacific Anatomic Pathology Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 217. Asia-Pacific Anatomic Pathology Market Size, by Software, 2017-2032 (USD Million)
TABLE 218. Asia-Pacific Anatomic Pathology Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 219. Asia-Pacific Anatomic Pathology Market Size, by Specimen Discipline, 2017-2032 (USD Million)
TABLE 220. Asia-Pacific Anatomic Pathology Market Size, by Diagnostic Technique, 2017-2032 (USD Million)
TABLE 221. Asia-Pacific Anatomic Pathology Market Size, by Clinical Purpose, 2017-2032 (USD Million)
TABLE 222. Asia-Pacific Anatomic Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Asia-Pacific Anatomic Pathology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 224. Asia-Pacific Anatomic Pathology Market Size, by Commercial Access Model, 2017-2032 (USD Million)
TABLE 225. Asia-Pacific Anatomic Pathology Market Size, by Route to Market, 2017-2032 (USD Million)
TABLE 226. Latin America Anatomic Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 227. Latin America Anatomic Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 228. Latin America Anatomic Pathology Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 229. Latin America Anatomic Pathology Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 230. Latin America Anatomic Pathology Market Size, by Software, 2017-2032 (USD Million)
TABLE 231. Latin America Anatomic Pathology Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 232. Latin America Anatomic Pathology Market Size, by Specimen Discipline, 2017-2032 (USD Million)
TABLE 233. Latin America Anatomic Pathology Market Size, by Diagnostic Technique, 2017-2032 (USD Million)
TABLE 234. Latin America Anatomic Pathology Market Size, by Clinical Purpose, 2017-2032 (USD Million)
TABLE 235. Latin America Anatomic Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. Latin America Anatomic Pathology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 237. Latin America Anatomic Pathology Market Size, by Commercial Access Model, 2017-2032 (USD Million)
TABLE 238. Latin America Anatomic Pathology Market Size, by Route to Market, 2017-2032 (USD Million)
TABLE 239. Middle East Anatomic Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 240. Middle East Anatomic Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 241. Middle East Anatomic Pathology Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 242. Middle East Anatomic Pathology Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 243. Middle East Anatomic Pathology Market Size, by Software, 2017-2032 (USD Million)
TABLE 244. Middle East Anatomic Pathology Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 245. Middle East Anatomic Pathology Market Size, by Specimen Discipline, 2017-2032 (USD Million)
TABLE 246. Middle East Anatomic Pathology Market Size, by Diagnostic Technique, 2017-2032 (USD Million)
TABLE 247. Middle East Anatomic Pathology Market Size, by Clinical Purpose, 2017-2032 (USD Million)
TABLE 248. Middle East Anatomic Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Middle East Anatomic Pathology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 250. Middle East Anatomic Pathology Market Size, by Commercial Access Model, 2017-2032 (USD Million)
TABLE 251. Middle East Anatomic Pathology Market Size, by Route to Market, 2017-2032 (USD Million)
TABLE 252. Africa Anatomic Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 253. Africa Anatomic Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 254. Africa Anatomic Pathology Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 255. Africa Anatomic Pathology Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 256. Africa Anatomic Pathology Market Size, by Software, 2017-2032 (USD Million)
TABLE 257. Africa Anatomic Pathology Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 258. Africa Anatomic Pathology Market Size, by Specimen Discipline, 2017-2032 (USD Million)
TABLE 259. Africa Anatomic Pathology Market Size, by Diagnostic Technique, 2017-2032 (USD Million)
TABLE 260. Africa Anatomic Pathology Market Size, by Clinical Purpose, 2017-2032 (USD Million)
TABLE 261. Africa Anatomic Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. Africa Anatomic Pathology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 263. Africa Anatomic Pathology Market Size, by Commercial Access Model, 2017-2032 (USD Million)
TABLE 264. Africa Anatomic Pathology Market Size, by Route to Market, 2017-2032 (USD Million)
TABLE 265. Global Anatomic Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 266. NATO Anatomic Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 267. NATO Anatomic Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 268. NATO Anatomic Pathology Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 269. NATO Anatomic Pathology Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 270. NATO Anatomic Pathology Market Size, by Software, 2017-2032 (USD Million)
TABLE 271. NATO Anatomic Pathology Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 272. NATO Anatomic Pathology Market Size, by Specimen Discipline, 2017-2032 (USD Million)
TABLE 273. NATO Anatomic Pathology Market Size, by Diagnostic Technique, 2017-2032 (USD Million)
TABLE 274. NATO Anatomic Pathology Market Size, by Clinical Purpose, 2017-2032 (USD Million)
TABLE 275. NATO Anatomic Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. NATO Anatomic Pathology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 277. NATO Anatomic Pathology Market Size, by Commercial Access Model, 2017-2032 (USD Million)
TABLE 278. NATO Anatomic Pathology Market Size, by Route to Market, 2017-2032 (USD Million)
TABLE 279. G7 Anatomic Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 280. G7 Anatomic Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 281. G7 Anatomic Pathology Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 282. G7 Anatomic Pathology Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 283. G7 Anatomic Pathology Market Size, by Software, 2017-2032 (USD Million)
TABLE 284. G7 Anatomic Pathology Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 285. G7 Anatomic Pathology Market Size, by Specimen Discipline, 2017-2032 (USD Million)
TABLE 286. G7 Anatomic Pathology Market Size, by Diagnostic Technique, 2017-2032 (USD Million)
TABLE 287. G7 Anatomic Pathology Market Size, by Clinical Purpose, 2017-2032 (USD Million)
TABLE 288. G7 Anatomic Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. G7 Anatomic Pathology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 290. G7 Anatomic Pathology Market Size, by Commercial Access Model, 2017-2032 (USD Million)
TABLE 291. G7 Anatomic Pathology Market Size, by Route to Market, 2017-2032 (USD Million)
TABLE 292. European Union Anatomic Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 293. European Union Anatomic Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 294. European Union Anatomic Pathology Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 295. European Union Anatomic Pathology Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 296. European Union Anatomic Pathology Market Size, by Software, 2017-2032 (USD Million)
TABLE 297. European Union Anatomic Pathology Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 298. European Union Anatomic Pathology Market Size, by Specimen Discipline, 2017-2032 (USD Million)
TABLE 299. European Union Anatomic Pathology Market Size, by Diagnostic Technique, 2017-2032 (USD Million)
TABLE 300. European Union Anatomic Pathology Market Size, by Clinical Purpose, 2017-2032 (USD Million)
TABLE 301. European Union Anatomic Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 302. European Union Anatomic Pathology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 303. European Union Anatomic Pathology Market Size, by Commercial Access Model, 2017-2032 (USD Million)
TABLE 304. European Union Anatomic Pathology Market Size, by Route to Market, 2017-2032 (USD Million)
TABLE 305. BRICS Anatomic Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 306. BRICS Anatomic Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 307. BRICS Anatomic Pathology Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 308. BRICS Anatomic Pathology Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 309. BRICS Anatomic Pathology Market Size, by Software, 2017-2032 (USD Million)
TABLE 310. BRICS Anatomic Pathology Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 311. BRICS Anatomic Pathology Market Size, by Specimen Discipline, 2017-2032 (USD Million)
TABLE 312. BRICS Anatomic Pathology Market Size, by Diagnostic Technique, 2017-2032 (USD Million)
TABLE 313. BRICS Anatomic Pathology Market Size, by Clinical Purpose, 2017-2032 (USD Million)
TABLE 314. BRICS Anatomic Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 315. BRICS Anatomic Pathology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 316. BRICS Anatomic Pathology Market Size, by Commercial Access Model, 2017-2032 (USD Million)
TABLE 317. BRICS Anatomic Pathology Market Size, by Route to Market, 2017-2032 (USD Million)
TABLE 318. ASEAN Anatomic Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 319. ASEAN Anatomic Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 320. ASEAN Anatomic Pathology Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 321. ASEAN Anatomic Pathology Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 322. ASEAN Anatomic Pathology Market Size, by Software, 2017-2032 (USD Million)
TABLE 323. ASEAN Anatomic Pathology Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 324. ASEAN Anatomic Pathology Market Size, by Specimen Discipline, 2017-2032 (USD Million)
TABLE 325. ASEAN Anatomic Pathology Market Size, by Diagnostic Technique, 2017-2032 (USD Million)
TABLE 326. ASEAN Anatomic Pathology Market Size, by Clinical Purpose, 2017-2032 (USD Million)
TABLE 327. ASEAN Anatomic Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 328. ASEAN Anatomic Pathology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 329. ASEAN Anatomic Pathology Market Size, by Commercial Access Model, 2017-2032 (USD Million)
TABLE 330. ASEAN Anatomic Pathology Market Size, by Route to Market, 2017-2032 (USD Million)
TABLE 331. GCC Anatomic Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 332. GCC Anatomic Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 333. GCC Anatomic Pathology Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 334. GCC Anatomic Pathology Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 335. GCC Anatomic Pathology Market Size, by Software, 2017-2032 (USD Million)
TABLE 336. GCC Anatomic Pathology Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 337. GCC Anatomic Pathology Market Size, by Specimen Discipline, 2017-2032 (USD Million)
TABLE 338. GCC Anatomic Pathology Market Size, by Diagnostic Technique, 2017-2032 (USD Million)
TABLE 339. GCC Anatomic Pathology Market Size, by Clinical Purpose, 2017-2032 (USD Million)
TABLE 340. GCC Anatomic Pathology Market Size, by End User, 2017-2032 (USD Million)
TABLE 341. GCC Anatomic Pathology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 342. GCC Anatomic Pathology Market Size, by Commercial Access Model, 2017-2032 (USD Million)
TABLE 343. GCC Anatomic Pathology Market Size, by Route to Market, 2017-2032 (USD Million)
TABLE 344. Global Anatomic Pathology Market Size, by Country, 2017-2032 (USD Million)
TABLE 345. United States Anatomic Pathology Market Size, 2017-2032 (USD Million)
TABLE 346. United States Anatomic Pathology Market Size, by Offering, 2017-2032 (USD Million)
TABLE 347. United States Anatomic Pathology Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 348. United States Anatomic Pathology Market Size, by Instruments & Equipment, 2017-2032 (USD Million)
TABLE 349. United States Anatomic Pathology Market Size, by Software, 2017-2032 (USD Million)
TABLE 350. United States Anatomic Pathology Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 351. United States Anatomic Pathology Market Size, by Specimen Discipline, 2017-2032 (USD Million)
TABLE 352. United States Anatomic Pathology Market Size, by Diagnostic Technique, 2017-2032 (USD Million)
TABLE 353. U

Companies Mentioned

  • Roche Holding Ltd
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • PHC Holdings Corporation
  • Sakura Finetek Japan Co., Ltd.
  • Hamamatsu Photonics K.K.
  • Koninklijke Philips N.V.
  • Hologic, Inc.
  • Becton, Dickinson and Company
  • Milestone SpA
  • 3DHISTECH Kft.
  • Bio-Optica Milano S.p.A.
  • Histo-Line Laboratories S.r.l.
  • Dakewe Biotech Co., Ltd.
  • KONFOONG BIOINFORMATION TECH CO., LTD.
  • NICHIREI BIOSCIENCES INC.
  • AMOS SCIENTIFIC PTY. LTD.
  • Erviegas Quimica Fina e Plasticos Ltda
  • PathAI, Inc.
  • Proscia Inc.
  • Ibex Medical Analytics Ltd.
  • Indica Labs, LLC
  • Aiforia Technologies Plc
  • Lunit Inc.
  • Sectra AB
  • PathPresenter Inc.
  • Tribun Health SAS
  • Grundium Oy
  • OptraSCAN Inc.
  • BioGenex Laboratories, Inc.
  • Guangdong Jinquan Medical Technology Co., Ltd.
  • Techcyte, Inc.
  • Avantik
  • Charles River Laboratories International, Inc.
  • GPI S.p.A.
  • Inpeco SA
  • LigoLab Information Systems
  • Labcorp Holdings Inc.
  • Sonic Healthcare Limited
  • Quest Diagnostics Incorporated
  • SYNLAB Holdco GmbH
  • Neogenomics Laboratories, Inc.

Table Information

Report AttributeDetails
No. of Pages180
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 44.8 Billion
Forecasted Market Value ( USD ) by 2032 $ 75.04 Billion
Compound Annual Growth Rate8.9%
Regions CoveredGlobal
No. of Companies Mentioned42

Related Topics

Related Reports

Anatomic Pathology Track & Trace Solution Market - Global Forecast 2026-2032 - Product Image

Anatomic Pathology Track & Trace Solution Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Anatomic Pathology Testing Market - Global Forecast 2026-2032 - Product Image

Anatomic Pathology Testing Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Anatomic Pathology Market - Products and Applications - Product Image

Anatomic Pathology Market - Products and Applications

  • Report
  • 256 Pages
  • Global
From
Anatomic Pathology - Global Strategic Business Report - Product Image

Anatomic Pathology - Global Strategic Business Report

  • Report
  • 377 Pages
  • Global
From
Anatomic Pathology Market by Product, Process, Disease, End User, Services, Model - Global Forecast to 2031 - Product Image

Anatomic Pathology Market by Product, Process, Disease, End User, Services, Model - Global Forecast to 2031

  • Report
  • 458 Pages
  • Global
From

About the Anatomic Pathology Market

The Anatomic Pathology market within the context of In Vitro Diagnostics is a specialized field of medicine that focuses on the diagnosis and characterization of diseases through the examination of tissue samples. It is a key component of the In Vitro Diagnostics industry, as it provides the necessary information to accurately diagnose and treat diseases. Anatomic Pathology is used to detect and diagnose a wide range of diseases, including cancer, infectious diseases, and genetic disorders. It is also used to monitor the progression of diseases and to assess the effectiveness of treatments. Anatomic Pathology is a highly specialized field, and requires specialized equipment and expertise. It is typically performed in a laboratory setting, and requires the use of sophisticated instruments such as microscopes, automated staining systems, and digital imaging systems. Some of the major companies in the Anatomic Pathology market include Agilent Technologies, Abbott Laboratories, Becton Dickinson, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.